Oleandomycin
From Wikipedia, the free encyclopedia
|
Oleandomycin
|
|
| Systematic (IUPAC) name | |
| (3R,5R,6S,7R,8R,11R,12S,13R,14S,15S)-14-((2S,3R,4S,6R)-4-(dimethylamino) -3-hydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)-6-hydroxy-12-((2R,4S,5S,6S) -5-hydroxy-4-methoxy-6-methyltetrahydro-2H-pyran-2-yloxy)-5,7,8,11,13,15 -hexamethyl-1,9-dioxaspiro[2.13]hexadecane-4,10-dione |
|
| Identifiers | |
| CAS number | |
| ATC code | J01 |
| PubChem | |
| Chemical data | |
| Formula | C35H61NO12 |
| Mol. mass | 687.858 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Oleandomycin is a macrolide antibiotic.
|
|||||||||||

